Baracaldo-Santamaria, D
Understanding the Trio: How Each Medication Works To understand the impact of taking three different diabetes medications, we must first look at their distinct roles in the body
The present study In this large, retrospective cohort study of people with type 2 diabetes from the TriNet X research network in the US, Gallagher and colleagues compared the development of chronic cough within 5 years in 427,555 people initiated on GLP-1 RAs from 2005 to 2025 versus 1,614,495 people who initiated any other second-line glucose-lowering drugs (including sulfonylureas, SGLT2 inhibitors and DPP-4 inhibitors)
It can also be combined with Tesamorelin or AOD 9604 for patients with multiple fat loss mechanisms to address
TAM: F (1,21) = 16.13, p = 0.0006
GLP-1 receptor agonists like semaglutide (Ozempic), liraglutide (Victoza), and tirzepatide (Mounjaro) help by increasing insulin secretion in response to meals, thereby lowering blood sugar levels